Arrowstreet Capital, Limited Partnership Surmodics Inc Call Options Transaction History
Arrowstreet Capital, Limited Partnership
- $121 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SRDX
# of Institutions
126Shares Held
11.7MCall Options Held
1.4KPut Options Held
8.6K-
Black Rock Inc. New York, NY1.17MShares$45.9 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.04MShares$40.8 Million0.01% of portfolio
-
Beryl Capital Management LLC Redondo Beach, CA989KShares$38.8 Million14.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA804KShares$31.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY753KShares$29.5 Million0.0% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $549M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...